SCHEMBL16626126

SCHEMBL16626126

FC(F)(c1ccccc1)C(F)(F)c1ccccn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CHRM2 P08172 1/20 0.45
AHR P35869 1/20 0.41
TSHR P16473 3/20 0.41
ALDH1A1 P00352 1/20 0.41
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
BLM P54132 3/20 0.38
CYP2D6 P10635 1/20 0.38
CETP P11597 6/20 0.37
CHRM3 P20309 1/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CCR1 P32246 1/20 0.36
CCR5 P51681 1/20 0.36
CCR8 P51685 1/20 0.36
METAP1 P53582 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13330613 0.81 SMN1; SMN2 (0.50) SMN1; SMN2L3MBTL1CHRM2AHRTSHR
SCHEMBL9065871 0.80 SMN1; SMN2 (0.54) SMN1; SMN2L3MBTL1CHRM2AHRALDH1A1
SCHEMBL29582316 0.80 SMN1; SMN2 (0.54) SMN1; SMN2L3MBTL1CHRM2AHRALDH1A1
SCHEMBL18680113 0.77 SMN1; SMN2 (0.50) SMN1; SMN2L3MBTL1CHRM2AHRMEN1
SCHEMBL11553320 0.77 SMN1; SMN2 (0.50) SMN1; SMN2L3MBTL1CHRM2AHRALDH1A1
SCHEMBL9723026 0.76 ALDH1A1 (0.65) TSHRALDH1A1CYP1A2CYP3A4ALOX15
SCHEMBL31324682 0.76 L3MBTL1 (0.54) SMN1; SMN2L3MBTL1CHRM2AHRTSHR
SCHEMBL4327683 0.76 L3MBTL1 (0.54) SMN1; SMN2L3MBTL1CHRM2AHRTSHR
SCHEMBL13053153 0.76 L3MBTL1 (0.54) SMN1; SMN2L3MBTL1CHRM2AHRTSHR
SCHEMBL5041519 0.75 SMN1; SMN2 (0.58) SMN1; SMN2L3MBTL1AHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE49222-E1 Fluorine-containing complex compound, and production method for fluorine-containing organic compound employing same DAIKIN INDUSTRIES, LTD. (JP) 2022-09-27 US disclosed
CN-112047913-A Fluorine-containing complex compound and method for producing fluorine-containing organic compound using same 大金工业株式会社 2020-12-08 CN disclosed
CN-111961068-A Fluorine-containing complex compound and method for producing fluorine-containing organic compound using same 大金工业株式会社 2020-11-20 CN disclosed
US-9802963-B2 Fluorine-containing complex compound, and production method for fluorine-containing organic compound employing same DAIKIN INDUSTRIES, LTD. (JP) 2017-10-31 US disclosed
US-9802963-B2 Fluorine-containing complex compound, and production method for fluorine-containing organic compound employing same DAIKIN INDUSTRIES, LTD. (JP) 2017-10-31 US disclosed
US-9802963-B2 Fluorine-containing complex compound, and production method for fluorine-containing organic compound employing same DAIKIN INDUSTRIES, LTD. (JP) 2017-10-31 US disclosed
US-20160214999-A1 FLUORINE-CONTAINING COMPLEX COMPOUND, AND PRODUCTION METHOD FOR FLUORINE-CONTAINING ORGANIC COMPOUND EMPLOYING SAME DAIKIN INDUSTRIES, LTD. (JP) 2016-07-28 US disclosed
US-20160214999-A1 FLUORINE-CONTAINING COMPLEX COMPOUND, AND PRODUCTION METHOD FOR FLUORINE-CONTAINING ORGANIC COMPOUND EMPLOYING SAME DAIKIN INDUSTRIES, LTD. (JP) 2016-07-28 US disclosed
US-20160214999-A1 FLUORINE-CONTAINING COMPLEX COMPOUND, AND PRODUCTION METHOD FOR FLUORINE-CONTAINING ORGANIC COMPOUND EMPLOYING SAME DAIKIN INDUSTRIES, LTD. (JP) 2016-07-28 US disclosed
WO-2015050236-A1 FLUORINE-CONTAINING COMPLEX COMPOUND, AND PRODUCTION METHOD FOR FLUORINE-CONTAINING ORGANIC COMPOUND EMPLOYING SAME ダイキン工業株式会社 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160214999-A1 FLUORINE-CONTAINING COMPLEX COMPOUND, AND PRODUCTION METHOD FOR FLUORINE-CONTAINING ORGANIC COMPOUND EMPLOYING SAME AFF1, AFF2, AFF4 SMN1; SMN2 981/4885L3MBTL1 3094/4885CHRM2 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.